Post-market Review of Ezetimibe – Revised Draft Report Public Consultation

Page last updated: 19 May 2017

The public consultation on the revised draft Ezetimibe Post-market Review Report to the PBAC will open on Tuesday 23 May 2017 and close at 5pm Tuesday 6 June 2017.

Interested organisations and individuals will be invited to provide a submission addressing the revised Draft Report to the Pharmaceutical Benefits Advisory Committee (PBAC). To make a submission please go to the Public Consultation page after 23 May.

Further information about the Review is available on the Ezetimibe Review page.